Submit Deal
All corporates
Similar corporates
Summary
Addimmune is a clinical-stage gene and cell therapy company developing a functional cure for HIV
Deals Overview
Market Context
All Corporates
Back to top
All rights reserved. Copyright © 2025 Datasite
Senior Management
Kathy Fowler
Media Contact
Deals (1)
Service Providers
Relationships
Portfolio
Team
Sort
Target: ADDIMMUNE
Bidder: 10X CAPITAL VENTURE ACQUISITION III
4 Service Providers
4 Dealmakers
£ 627 M
Value
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy